Russia Claims to Have “Effective” Ebola Vaccine

WHO wants to see the study data

Russia’s health minister Veronika Skovortsova said on February 15 that an Ebola vaccine developed by her country during the last 15 months has shown encouraging results and would undergo further testing in West Africa, according to a report posted on the Medical Xpress website.

“Phases 1 and 2 of testing were managed in Russia with volunteers and showed that the vaccine was very effective,” Skovortsova told reporters in Geneva. She said the vaccine––GamEvac-Combi––would be put to additional tests in Guinea.

The West African countries of Guinea, Liberia, and Sierra Leone have been hardest-hit by the worst-ever Ebola outbreak, which has killed more than 11,300 people since December 2013.

According to Skovortsova, the preliminary testing showed limited adverse effects in isolated cases, including headaches and slight body temperature rises. Russian officials who led the testing said the sequential injections led to a surge in antibody production among the trial subjects.

The World Health Organization responded that it had heard of the Russian vaccine but had not yet seen the study data. The WHO was hoping to study the Russian findings before giving an opinion on the new vaccine.

To date, no approved vaccine or treatment for Ebola exists, and the WHO has authorized the fast-track development of such drugs.

Source: Medical Xpress(link is external); February 15, 2016.

More Headlines

MultiStem product does not require tissue matching or immune suppression
Two pulmonary embolism deaths linked to MetAP2 inhibitor
Alternative to tubal ligation has drawn thousands of complaints
Injection could result in coma and death
Monoclonal antibody blocks tumor cells’ attempts to evade detection
NSAIDs are preferred therapy for active AS